Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis

被引:0
|
作者
Alessandro Giollo
Giovanni Cioffi
Federica Ognibeni
Giovanni Orsolini
Andrea Dalbeni
Riccardo Bixio
Giovanni Adami
Angelo Fassio
Luca Idolazzi
Davide Gatti
Maurizio Rossini
Ombretta Viapiana
机构
[1] University of Verona Hospital Trust,Rheumatology Section, Department of Medicine
[2] University of Padova,Division of Rheumatology
[3] S. Pancrazio Hospital,Division of Cardiac Rehabilitation
[4] University of Verona Hospital Trust,Internal Medicine and Hypertension Section, Department of Medicine
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Biologic Agents Reduce Cardiovascular Events in Rheumatoid Arthritis Not Responsive to Tumour Necrosis Factor Inhibitors: A National Cohort Study
    Hsieh, Ming-Jer
    Lee, Cheng-Hung
    Tsai, Ming-Lung
    Kao, Chang-Fu
    Lan, Wen-Ching
    Huang, Yu-Tung
    Tseng, Wen-Yi
    Wen, Ming-Shien
    Chang, Shang-Hung
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (11) : 1739 - 1746
  • [42] Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors
    Segan, J.
    Staples, M. P.
    March, L.
    Lassere, M.
    Chakravarty, E. F.
    Buchbinder, R.
    [J]. INTERNAL MEDICINE JOURNAL, 2015, 45 (03) : 310 - 318
  • [43] A MODEL TO EVALUATE THE IMMUNOGENICITY COSTS OF TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Heeg, B.
    Majer, I
    Stephens, J. M.
    Tarallo, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A563 - A563
  • [44] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Moreland, LW
    [J]. PHARMACOECONOMICS, 2004, 22 (02) : 39 - 53
  • [45] Long Term Safety and Effectiveness of Tumour Necrosis Factor Inhibitors In Systemic Sclerosis Patients with Arthritis
    Omair, Mohammed
    Phumethum, Veerapong
    Johnson, Sindhu R.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S577 - S577
  • [46] Drugs that block tumour necrosis factor: Experience in patients with rheumatoid arthritis
    Larry W. Moreland
    [J]. PharmacoEconomics, 2004, 22 : 39 - 53
  • [47] Tumour necrosis factor a −308 promoter polymorphism in patients with rheumatoid arthritis
    Zahra Rezaieyazdi
    Jalil Tavakol Afshari
    Mahnaz Sandooghi
    Farnaz Mohajer
    [J]. Rheumatology International, 2007, 28 : 189 - 191
  • [48] Marantic Endocarditis in a Long-Standing Untreated Rheumatoid Arthritis Patient
    Duggal, Priya
    Patki, Swati Shripad
    Sarkar, Soumajyoti
    Godbout, Regina
    Raychaudhuri, Siba P.
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (8S) : S819 - S820
  • [49] ADALIMUMAB (HUMIRA®) INHIBITS RADIOGRAPHIC PROGRESSION IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH LONG-STANDING DISEASE: DATA AT TWO YEARS
    Keystone, E.
    Kavanaugh, A.
    Sharp, J.
    Spencer-Green, G.
    Segurado, O. G.
    [J]. RHEUMATOLOGY, 2004, 43 : 10 - 10
  • [50] BASILAR INVAGINATION: AN UNCOMMON COMPLICATION OF LONG-STANDING RHEUMATOID ARTHRITIS
    Shah, Qutab F.
    Harkins, Patricia
    Gorman, Aine
    Camon, Angela
    Mohammad, Ausaf
    O'Rourke, Killian
    [J]. RHEUMATOLOGY, 2019, 58